Effects Of Oral Levosimendan (ODM-109) On Respiratory Function In Patients With ALS: Open-Label Extension For Patients Completing Study 3119002

Grants and Contracts Details

StatusFinished
Effective start/end date9/16/199/16/19

Funding

  • Pharmaceutical Research Associates